Literature DB >> 4005111

Investigation of drug absorption from the gastrointestinal tract of man. II. Metoprolol in the jejunum and ileum.

N Vidon, D Evard, J Godbillon, M Rongier, M Duval, J P Schoeller, J J Bernier, J Hirtz.   

Abstract

Absorption of metoprolol in jejunum and ileum was investigated in eight healthy subjects using an intestinal perfusion technique below an occlusive balloon. An isotonic saline solution, with or without metoprolol, was perfused at a flow rate of 10 ml/min, either at the angle of Treitz or in the middle part of the ileum. The absorption in a 30 cm intestinal segment was evaluated at metoprolol concentrations of 20, 40 and 60 mg/l. Metoprolol did not affect gut motility. Metoprolol was similarly absorbed in the jejunum and ileum. The absorption rates appeared to be linearly related to the perfusion rates and to the mean concentration in the segment, indicating a first-order kinetic process. The absorption rate of metoprolol perfused in the jejunum in a saline solution appeared to be lower than that observed after gastric administration of the drug incorporated in a meal. The findings in this and other studies in this series indicate that metoprolol is similarly absorbed throughout the small intestine.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4005111      PMCID: PMC1463762          DOI: 10.1111/j.1365-2125.1985.tb02750.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  8 in total

1.  Enhancement of the bioavailability of propranolol and metoprolol by food.

Authors:  A Melander; K Danielson; B Scherstén; E Wåhlin
Journal:  Clin Pharmacol Ther       Date:  1977-07       Impact factor: 6.875

Review 2.  Gastrointestinal absorption of drugs.

Authors:  L F Prescott
Journal:  Med Clin North Am       Date:  1974-09       Impact factor: 5.456

3.  [Transit time and calibre of the small intestine in man: measurement by a dye dilution curve during intestinal perfusion of isotonic solutions of NaCl and KCl].

Authors:  C Matuchansky; D Sterin; J C Rambaud; J J Bernier
Journal:  Biol Gastroenterol (Paris)       Date:  1969

4.  Investigation of drug absorption from the gastrointestinal tract of man. IV. Influence of food and digestive secretions on metoprolol jejunal absorption.

Authors:  D Evard; N Vidon; J Godbillon; M Bovet; M Duval; J P Schoeller; J J Bernier; J Hirtz
Journal:  Br J Clin Pharmacol       Date:  1985       Impact factor: 4.335

5.  Occlusion of the jejunum for intestinal perfusion in man.

Authors:  S F Phillips; W H Summerskill
Journal:  Mayo Clin Proc       Date:  1966-04       Impact factor: 7.616

6.  Influence of isoproterenol and propranolol on human intestinal transport in vivo.

Authors:  A I Morris; L A Turnberg
Journal:  Gastroenterology       Date:  1981-12       Impact factor: 22.682

7.  Investigation of drug absorption from the gastrointestinal tract of man. III. Metoprolol in the colon.

Authors:  J Godbillon; D Evard; N Vidon; M Duval; J P Schoeller; J J Bernier; J Hirtz
Journal:  Br J Clin Pharmacol       Date:  1985       Impact factor: 4.335

8.  Investigation of drug absorption from the gastrointestinal tract of man. I. Metoprolol in the stomach, duodenum and jejunum.

Authors:  G Jobin; A Cortot; J Godbillon; M Duval; J P Schoeller; J Hirtz; J J Bernier
Journal:  Br J Clin Pharmacol       Date:  1985       Impact factor: 4.335

  8 in total
  19 in total

1.  Influence of splitting on dissolution properties of metoprolol tablets.

Authors:  Edina Vranić; Alija Uzunović
Journal:  Bosn J Basic Med Sci       Date:  2009-08       Impact factor: 3.363

2.  Absorption of propranolol in humans following oral, jejunal, and ileal administration.

Authors:  A Buch; W H Barr
Journal:  Pharm Res       Date:  1998-06       Impact factor: 4.200

3.  Estimate of volume/flow ratio of gastrointestinal (GI) fluids in humans using pharmacokinetic data.

Authors:  P Macheras; C Reppas; J B Dressman
Journal:  Pharm Res       Date:  1990-05       Impact factor: 4.200

4.  G.L. Amidon, H. Lennernas, V.P. Shah, and J.R. Crison. A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability, Pharm Res 12, 413-420, 1995--backstory of BCS.

Authors:  Vinod P Shah; Gordon L Amidon
Journal:  AAPS J       Date:  2014-06-25       Impact factor: 4.009

5.  Extended release delivery system of metoprolol succinate using hot-melt extrusion: effect of release modifier on methacrylic acid copolymer.

Authors:  Kiran P Sawant; Ritesh Fule; Mohammed Maniruzzaman; Purnima D Amin
Journal:  Drug Deliv Transl Res       Date:  2018-12       Impact factor: 4.617

6.  Jejunal and ileal absorption of oxprenolol in man: influence of nutrients and digestive secretions on jejunal absorption and systemic availability.

Authors:  J Godbillon; N Vidon; R Palma; A Pfeiffer; C Franchisseur; M Bovet; G Gosset; J J Bernier; J Hirtz
Journal:  Br J Clin Pharmacol       Date:  1987-09       Impact factor: 4.335

Review 7.  The gastrointestinal absorption of drugs in man: a review of current concepts and methods of investigation.

Authors:  J Hirtz
Journal:  Br J Clin Pharmacol       Date:  1985       Impact factor: 4.335

8.  Effect of Roux-en-Y gastric bypass on the bioavailability of metoprolol from immediate and controlled release tablets: a single oral dose study before and after surgery.

Authors:  Jan Peter Yska; Jacquelien T M Wanders; Blessing Odigie; Jan A Apers; Marloes Emous; Erik R E Totté; E Christiaan Boerma; Froukje L Ubels; Herman J Woerdenbag; Henderik W Frijlink; Bob Wilffert; Eric N van Roon
Journal:  Eur J Hosp Pharm       Date:  2019-02-15

9.  Comparison of the permeability of metoprolol and labetalol in rat, mouse, and Caco-2 cells: use as a reference standard for BCS classification.

Authors:  Tuba Incecayir; Yasuhiro Tsume; Gordon L Amidon
Journal:  Mol Pharm       Date:  2013-02-04       Impact factor: 4.939

10.  Drug disposition and modelling before and after gastric bypass: immediate and controlled-release metoprolol formulations.

Authors:  Ina Gesquiere; Adam S Darwich; Bart Van der Schueren; Jan de Hoon; Matthias Lannoo; Christophe Matthys; Amin Rostami; Veerle Foulon; Patrick Augustijns
Journal:  Br J Clin Pharmacol       Date:  2015-07-06       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.